HS-20124

HS-20124 · Hansoh BioMedical R&D Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HS-20124, covering 2025-01-08 to 2025-01-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study of HS-20124 in Patients with Advanced Solid Tumors [Phase 1]